Comparison between tafamidis and liver transplantation as first-line therapy for hereditary transthyretin amyloidosis-Reference-Cited by-同舟云学术

Comparison between tafamidis and liver transplantation as first-line therapy for hereditary transthyretin amyloidosis

Published:2023-02-16 Issue:3 Volume:30 Page:303-312
ISSN:1350-6129
Container-title:Amyloid
language:en
Short-container-title:Amyloid

Author:

Socie Pierre¹,Benmalek Anouar²,Cauquil Cécile³,Piekarski Eve⁴⁵,Kounis Ilias⁶⁷^ORCID,Eliahou Ludivine¹,Rousseau Antoine⁷⁸^ORCID,Rouzet François⁴⁵^ORCID,Echaniz-Laguna Andoni³⁷⁹^ORCID,Samuel Didier⁶⁷^ORCID,Adams David³⁷⁹^ORCID,Slama Michel S¹⁷,Algalarrondo Vincent¹⁵^ORCID

Affiliation:

1. Centre de Compétence des Amyloses Cardiaques, Service de Cardiologie, Hôpital Bichat Claude Bernard, AP-HP, Paris, France

2. Université Paris-Sud, Faculté de Pharmacie, Université Paris-Saclay, Chatenay Malabry, France

3. Service de Neurologie, Hôpital Bicêtre, AP-HP, Le Kremlin-Bicêtre, France and French Referral Center for Familial Amyloid Polyneuropathy and Other Rare Peripheral Neuropathies (NNERF), Bicêtre, France

4. Service de Médecine Nucléaire, Hôpital Bichat Claude Bernard, AP-HP, Paris, France

5. Université de Paris-Cité, Faculté de médecine, Paris, France

6. Centre Hépatobiliaire, Hôpital Paul Brousse, AP-HP, Villejuif, France

7. Service d'Ophtalmologie, Hôpital Bicêtre, AP-HP, Le Kremlin-Bicêtre, France

8. Université Paris-Sud, Faculté de Médecine, Université Paris-Saclay, Le Kremlin-Bicêtre, France

9. INSERM, UMR 1195, Le Kremlin Bicêtre, France

Publisher

Informa UK Limited

Subject

Internal Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13506129.2023.2177986